Product Information

GABAPENTIN 250 MG/5 ML SOLN is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.0887 per ML under NDC 59762505007. Its NADAC has been published 207 times since Sep 7, 2022.

FDA first approved this application on Mar 2, 2000. Its Orange Book therapeutic-equivalence code is AA.

GABAPENTIN 250 MG/5 ML SOLN

gabapentin
$0.0887per ML

Strength

250 mg/5mL

NDC

59762505007

Classification

Generic

Dosage Form

SUSPENSION

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

GABAPENTIN

Approval Type

Authorized Generic (NDA)

FDA Application

NDA021129

FDA Approved

3/2/2000

TE Code

AA

On Market Since

7/1/2022

Pharmacological Classes

Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for GABAPENTIN 250 MG/5 ML SOLN has been published 207 times since Sep 7, 2022, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.0887 per ML
All-time high$0.1379 (Sep 13, 2023)
All-time low$0.0768 (Nov 20, 2024)
52-week high$0.0895
52-week low$0.0825
Median price$0.0918
Average price$0.1005
Largest weekly change-23.5% (Apr 17, 2024)
Weeks tracked207
Tracking sinceSep 7, 2022

Price History

1W

+3.0%

1M

+7.4%

3M

+5.7%

6M

+4.0%

1Y

+0.5%

3Y

-21.2%

5Y

N/A

All

+0.7%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the gabapentin market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of GABAPENTIN 250 MG/5 ML SOLN?

The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 250 MG/5 ML SOLN, manufactured by Mylan Pharmaceuticals Inc., is $0.0887 per ML (NDC 59762505007), effective Aug 19, 2026.

How has the price of GABAPENTIN 250 MG/5 ML SOLN changed over time?

Over the history we have for it, the NADAC for GABAPENTIN 250 MG/5 ML SOLN has held within roughly two percent of its current level. It has been tracked across 207 weekly CMS publications since Sep 7, 2022.

What are the highest and lowest recorded NADAC prices for GABAPENTIN 250 MG/5 ML SOLN?

Since Sep 7, 2022, the NADAC for GABAPENTIN 250 MG/5 ML SOLN has ranged from a low of $0.0768 (Nov 20, 2024) to a high of $0.1379 (Sep 13, 2023), with a median of $0.0918 per ML.

Are there cheaper alternatives to GABAPENTIN 250 MG/5 ML SOLN?

No other NADAC-published product currently shares the active ingredient and strength of GABAPENTIN 250 MG/5 ML SOLN in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures GABAPENTIN 250 MG/5 ML SOLN?

GABAPENTIN 250 MG/5 ML SOLN (NDC 59762505007) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.